Sage Therapeutics, Inc. 4
4 · Sage Therapeutics, Inc. · Filed Feb 8, 2017
Insider Transaction Report
Form 4
Kanes Stephen
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2017-02-06+40,000→ 40,000 totalExercise: $47.70Exp: 2027-02-06→ Common Stock (40,000 underlying)
Footnotes (1)
- [F1]The securities awarded on 2/06/2017 were in the form of stock options issued pursuant to the Sage Therapeutics, Inc. 2014 Stock Option and Incentive Plan. Options to purchase 5,000 shares of common stock shall vest on the one year anniversary of the Vesting Start Date with 15,000 shares vesting in 36 equal monthly installments thereafter. Options to purchase 20,000 shares of common stock shall vest periodically over the next four years upon the Company achieving certain milestones.